World News: 21:05 GMT Thursday 6th December 2018. [Aeglea BioTherapeutics, Inc. via Globe Newswire via SPi World News]
AUSTIN Texas Dec 06 2018 GLOBE NEWSWIRE -- Aeglea BioTherapeutics Inc NASDAQ AGLE a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer, will p...
Globe Newswire: 21:05 GMT Thursday 6th December 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.